The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of AMICOPE Intervention to Maintain Self-Perceived Health and Intrinsic Capacity in Older People (EFICIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05249504
Recruitment Status : Not yet recruiting
First Posted : February 21, 2022
Last Update Posted : February 21, 2022
Sponsor:
Information provided by (Responsible Party):
Fundacio Salut i Envelliment UAB

Tracking Information
First Submitted Date  ICMJE December 15, 2021
First Posted Date  ICMJE February 21, 2022
Last Update Posted Date February 21, 2022
Estimated Study Start Date  ICMJE April 1, 2022
Estimated Primary Completion Date June 30, 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: February 10, 2022)
Self-perceived health [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
Change in self-perceived health status according to the Euroqol Visual Analogue Scale, where participants scores from 0 (worse state) to 100 (better state) their current perceived health
Original Primary Outcome Measures  ICMJE Same as current
Change History No Changes Posted
Current Secondary Outcome Measures  ICMJE
 (submitted: February 10, 2022)
  • Functional status [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in functional status according to the Short Physical Performance Battery (SPPB), a set of tests that measure balance, gait speed and strength (raising 5 times from a chair). Persons are classified in categories according to their final score (0-3, 4-6, 7-9, 10-12). Higher scores indicates robustness, lower scores are indicative of frailty and disability.
  • Nutritional status [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in nutritional risks assessed by the abridged version of Mini-Nutritional Assessment (MNA), which classifies the persons as normal (12-14 points), at risk of malnutrition (8-11) or malnourished (0-7)
  • Depressive symptoms [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in proportion of participants with depressive symptoms using the 5 items Geriatric Depression Scales (GDS5). Not depressed (0 or 1 point), Depressed (2-5).
  • Autonomy in daily life. [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in the ability to perform basic and instrumental daily life activities will be measured with the Short-Form Late-Life Function and Disability Instrument (SF-LLFDI). Higher scores indicates a higher level of autonomy.
  • Health related quality of life. [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in health related quality of life will be assessed with the quality of life questionnaire EQ-5D-5L.
  • Physical activity. [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in level of physical activity, which will be assessed with the Spanish Short Version of the Minnesota Leisure Time Physical Activity Questionnaire (VREM), which according to the time doing several activities computes the energy expenditure in units that can be compared between them, the Metabolic Equivalent of Task. (MET). Persons are categorized as sedentary (< 1.250 METs-min/14 days), moderately active (1.250 to 2.999 METs-min/14 days); active (3.000 to 4.999 METs-min/14 days) or very active (≥ 5.000 METs-min/14 days).)
  • Loneliness [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in the degree of Loneliness, which will be assessed with De Jong Gierveld Loneliness Scale. The degree of loneliness is scored as no loneliness (0 to 2 points), mild loneliness ( 3 to 8), severe (9 to 10) or very severe (11)
  • Social support and risk of isolation [ Time Frame: Baseline, after the intervention (average 16 weeks) ]
    Change in social support and risk of isolation, which will be assessed with the Lubben Social Network Scale - Revised (LSNS-R). According the the LSNS-R score the persons will be classified as with low risk (30 to 60 points); mild (26 to 30); high (21 to 25) or socially isolated (0 to 20).
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Effectiveness of AMICOPE Intervention to Maintain Self-Perceived Health and Intrinsic Capacity in Older People
Official Title  ICMJE Efectividad de la intervención AMICOPE Para Mejorar y/o Mantener la Salud Autopercibida y la Capacidad intrínseca en Personas Mayores: un Ensayo clínico Aleatorizado (EFICIS)
Brief Summary

In their day to day, persons do from simple to more or less complicated tasks and activities (ie: stand from a chair, open a door, shopping, read, drive, play chess, remind an appointment...). Such ability to do things is called capacity. Intrinsic capacity is the combination of all the physical and mental capacities that a person has, and reach its maximum in the early adulthood and then declines as the person ages. Each kind of capacity declines at her own speed (which may be faster or slower according to each person lifestyle), and once drops below a threshold may lead to a reduction in quality of life and loss of autonomy.

Nevertheless there are some actions that may be effective to prevent or slow such decline. To do so the investigators have design an intervention that combines several things of different nature (what is know as a complex intervention) called AMICOPE. The AMICOPE intervention is performed in the community or in primary care centers through 12 weekly group sessions of 2 h 30 min which combine structured and adapted physical activity, group dynamics to promote social support and address loneliness, social isolation and depressive symptoms, and dietary advice.

Our study is addressed to persons over 70 with light problems in mobility, nutrition or mood state.

The purpose of this study is to assess if the AMICOPE intervention is better than the standard advice to follow healthy lifestyles to improve or maintain self-perceived health, mobility, nutritional status an psychological wellbeing.

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Open and Pragmatic Parallel Randomized Controlled Clinical Trial
Masking: None (Open Label)
Primary Purpose: Prevention
Condition  ICMJE
  • Mobility
  • Depressive Symptoms
  • Nutrition, Healthy
  • Cognitive Decline
  • Hearing Loss
  • Visual Impairment
Intervention  ICMJE
  • Other: VIVIFRAIL

    VIVIFRAIL is a set of physical activity programs (designed according to several elderly functional level profiles) aimed to prevent motor disability and improve quality of life. It works endurance, flexibility, balance and strength.

    https://web.archive.org/web/20210907041944/https://vivifrail.com/

  • Other: Nutrition
    Sessions to learn about personal nutrition habits, offer nutritional advice, and acquire skills to incorporate simple healthy nutrition guidelines into everyday life. A visit to a supermarket to make it easier to read and understand the basic information on nutrition labels.
  • Behavioral: Psychology
    Relaxation techniques to manage mood, a photo-elicitation dynamic to address loneliness, and a dynamic to collectively develop a map of health assets in the neighborhood or territory to obtain information on community resources. Finally, a group visit is planned to a community facility previously agreed upon by the participants.
  • Behavioral: Personal autonomy
    Review practical cases on personal autonomy, the proper use of medications, and discover basic cognitive stimulation strategies.
  • Other: Community resources
    Learn about community resources
  • Other: Standard recommendations
    Usual advice provided at primary care office accompanied to booklets about healthy lifestyles
Study Arms  ICMJE
  • Experimental: 1. Intervention group

    AMICOPE multicomponent intervention:

    • Physical activity (VIVIFRAIL program): 10 hours.
    • Nutrition: 6,5 hours.
    • Psychology: 6,5 hours.
    • Personal autonomy: 4,5 hours
    • Learn about community resources: 2, 5 hours
    Interventions:
    • Other: VIVIFRAIL
    • Other: Nutrition
    • Behavioral: Psychology
    • Behavioral: Personal autonomy
    • Other: Community resources
  • Active Comparator: 2. Control group
    Control group participants will receive usual advice on healthy lifestyle habits and a follow-up phone call from healthcare professionals.
    Intervention: Other: Standard recommendations
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Not yet recruiting
Estimated Enrollment  ICMJE
 (submitted: February 10, 2022)
212
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE August 31, 2024
Estimated Primary Completion Date June 30, 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

INCLUSION CRITERIA

  • To live in the community
  • To be able to move autonomously to the intervention place
  • To Have a deficit in at least one mobility, vitality or psychological domains in the Integrated Care for Older People (ICOPE) screening tool confirmed by a reference test, namely:

A - Mobility: unable to stand up from a chair 5 times in less than 14 seconds AND having less than 10 points in the Short Physical Performance Battery (SPPB).

B - Vitality: any nutritional problem from the ICOPE screening tool (loss of appetite OR losing more than 3 Kg not intentionally in the last 3 months) AND having less than 12 points in MNA (malnutrition or malnutrition risc).

C - Psychological: any depressive symptoms from the ICOPE screening tool (answer that in the last two weeks has had feelings of sadness, melancholy OR hopelessness or refer lack of interest or pleasure when doing things) AND the presence of at least two or more symptoms on the 5-item Geriatric Depression Scale (GDS5).

EXCLUSION CRITERIA

  • People with previous diagnosis of dementia or cognitive decline with a score below 24 points in the Minimental State Examination (MMSE).
  • People in the end of life.
  • People who have factors that prevent or contraindicate the performance of the planned interventions, such as contraindication to physical activity, mental or (non-corrected) communication issues that makes it difficult to participate in group dynamics.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 70 Years and older   (Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Listed Location Countries  ICMJE Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT05249504
Other Study ID Numbers  ICMJE FSIEPI2100537
PI21/00537 ( Other Grant/Funding Number: FIS )
5876 ( Other Identifier: CEEAH UAB )
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: Yes
Plan Description:

The sponsor only will share data from participants that have provided written consent to share its anonymized data for studies with scientific purposes related with well-being, quality of life and autonomy of the elderly persons.

Once the database is closed all identifying data collected to develop the study (ie: names and contact phones to make appointments) will be removed from the database.

Any date variable will be replaced by a time reference variable, taking as reference the day of the first visit (ie: instead of date of birth and date of visit, will be replaced by the age).

Other actions may be performed to ensure a reasonable balance between the data loss and the risk of re-identification, as editing quasi-identificatory variables (ie categorizing/aggregating participant data, as creating age groups) or removed (ie removing the data identifying the centers) or removing cases with a high degree of singularity given the quasi-identificatory variables combination.

Time Frame: The data can be requested 18 months after publishing the results.
Access Criteria:

Upon request by non-profit organizations. The purpose of the request must match the purpose for which the participants have given their sharing consent.

Requester must cite and recognize the source of the data in their works, as far as the funds that the project has received.

Current Responsible Party Fundacio Salut i Envelliment UAB
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Fundacio Salut i Envelliment UAB
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account Fundacio Salut i Envelliment UAB
Verification Date February 2022

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP